Will knowledge of the molecular pathology of lymphoma improve clinical trials?
David Maloney et al.
The lymphoma tumor microenvironment: therapeutic targeting, genetics, drug optimization
Laura Pasqualucci et al.
T-cell lymphomas: murine models, in-situ treatments & screening for HTLV1
David Weinstock et al.
Genetic basis of immune evasion in lymphoid malignancies: more heterogenetity than we think?
John Gribben et al.